Puma Biotechnology Inc (PBYI) Q4 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Puma Biotechnology Inc.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.738 Good afternoon. My name is Darrell and I will be your conference call operator today. 00:00:04.738 -- 00:00:08.143 At this time, all participants are in a listen-only mode. 00:00:08.143 -- 00:00:11.709 After the speaker's formal remarks, there will be a question and answer session. 00:00:11.709 -- 00:00:15.334 If you would like to ask a question during that time, simply press star key, then the 00:00:15.334 -- 00:00:19.580 number one on your telephone keypad. If you would like to withdraw your questions, please 00:00:19.580 -- 00:00:24.087 press star two. If you should require operator assistance during the conference, please 00:00:24.087 -- 00:00:28.246 press star zero. As a reminder, this call is being recorded. 00:00:28.246 -- 00:00:32.752 I would now like to turn the conference call over to Marianne O'Hanessian, Senior Director 00:00:32.752 -- 00:00:37.297 of IR for PUMA Biotechnology. You may begin your conference. 00:00:37.297 -- 00:00:41.863 Thank you, Darrell. Good afternoon and welcome to PUMA's conference call to discuss our 00:00:41.863 -- 00:00:45.187 earnings results for the fourth quarter of 2024. 00:00:45.187 -- 00:00:50.093 Joining me on the call today are Alan Auerbach, Chief Executive Officer, President and 00:00:50.093 -- 00:00:52.716 Chairman of the Board of PUMA Biotechnology, 00:00:52.716 -- 00:00:59.009 Maximo Noguez, Chief Financial Officer, and Jeff Ludwig, Chief Commercial Officer. 00:00:59.009 -- 00:01:03.374 After the close date, PUMA issued a news release detailing earnings results for the fourth 00:01:03.374 -- 00:01:05.597 quarter of 2024. That 00:01:05.597 -- 00:01:10.803 news release, slides that Jeff will refer to, and a webcast of this call are accessible 00:01:10.803 -- 00:01:16.707 via the homep...